The CD44-ECD in the synNotch receptor acts as a CD44 decoy receptor in the tumor microenvironment (TME), and after a ligand binds to the CD44-ECD, HIF-3α4 is released from the Notch core regulatory region at the cell membrane to inhibit the hypoxia-induced responses (Figure 1B). This evidence concerns the gene CD44 and neoplasm.